Medication info

Bazedoxifene Tablets 20 Milligrams (Bazedoxifene Acetate)

Prescription medicationTabletOralExpired
Ingredient · strength
Bazedoxifene Acetate›22.6mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
White or grayish-white capsule-shaped film-coated tablet
Packaging
28 tablets/box [(28 tablets/PTP)]
Approval status
Expired

MFDS item code 201904724 · Approved 2019.07.12

This product's status changed to Expired on 2024.07.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily (equivalent to 20mg of bazedoxifene), with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. No dosage adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: Administration of this drug is not recommended because its safety and efficacy have not been established in patients with hepatic impairment.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
  • vertebral fractures
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. It is particularly effective in reducing the occurrence of vertebral fractures, although its efficacy for non-vertebral fractures has not been conclusively proven. Therefore, it primarily helps to lower the risk of vertebral-related fractures.

How to take

Adult dose

Take 1 tablet once daily (equivalent to 20mg of bazedoxifene), with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. No dosage adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: Administration of this drug is not recommended because its safety and efficacy have not been established in patients with hepatic impairment.

Precautions

This medication is designed for use only in postmenopausal women. Taking this medication may increase the risk of venous thromboembolism, which is the formation of blood clots in the veins. This risk is particularly heightened in the first year of treatment, so caution is required. Women at high risk of thrombosis, such as older adults, those who are overweight, those who have prolonged periods of immobility, those recovering from surgery, or those with cancer, should avoid this medication. During long travels, it is also important to regularly move to prevent clots. Women who are pregnant or may become pregnant, nursing mothers, and those with allergies to this medication or its ingredients should not take this medication. Individuals with unexplained uterine bleeding or symptoms of endometrial cancer should also refrain from using this medication. This medication contains lactose, so individuals with lactose intolerance or certain genetic disorders should avoid taking it. Those with high triglyceride levels or issues with kidney or liver function should use this medication cautiously. Drowsiness or vision disturbances may occur while taking this medication, so caution is needed when driving or operating machinery. This medication has relatively few significant interactions with other drugs; however, when used with certain medications metabolized by the liver, drug concentrations may change, so consulting a specialist is necessary. In the event of overdose, there is no specific antidote, and treatment should be symptomatic. Keep out of reach of children, and it is safer to keep the medication in its original container. Some side effects or adverse reactions may occur with long-term use of this medication, so if bleeding or severe side effects occur during use, immediate consultation with medical personnel is necessary.

Side effects

  • Hypersensitivity
  • drowsiness
  • retinal vein thrombosis
  • facial flushing
  • deep vein thrombosis
  • superficial thrombophlebitis
  • pulmonary embolism
  • dry mouth
  • urticaria
  • rash
Show 16 more
  • itching
  • muscle cramps
  • peripheral edema
  • increased serum triglycerides
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • decreased vision
  • blurred vision
  • photopsia
  • visual field defect
  • visual impairment
  • keratoconjunctivitis sicca
  • eyelid edema
  • eyelid spasm
  • eye pain
  • eye swelling

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture, and it is advisable to keep it at a cool temperature below 25 degrees Celsius. This helps maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

White or grayish-white capsule-shaped film-coated tablet

Package unit

28 tablets/box [(28 tablets/PTP)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.